Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Elevance Health, formerly Anthem, is a US health insurer. The company runs plans under the Blue Cross Blue Shield brand in many states, for employers, Medicaid and Medicare, and offers health and pharmacy services through Carelon. As of Oct 13, 2026
As of Oct 13, 2026Fact sheet (from the annual report)Health insurance and health plans · Indianapolis, USAfull fact sheet
Elevance Health is a health insurer in the United States with managed care plans for individuals, employer groups and for Medicaid and Medicare. As an independent licensee of Blue Cross and Blue Shield, the company operates in California, Colorado, Georgia and Indiana, among other states. The Health Benefits segment offers full-risk health insurance as well as dental, vision and supplemental insurance. The CarelonRx segment provides pharmacy services such as mail-order and specialty pharmacies, claims processing and formularies for its own and external customers. In March 2024 the acquisition of Paragon Healthcare added outpatient infusion centers to CarelonRx.
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Detected chart patterns
Warning pattern Double top on the 4-hour chart, detected on Nov 18, 2026, 15:30
Free with an account until Jan 31, 2027: all Premium features, no subscription and no card. Sign up free
Earlier patterns · Past performance, not a forecast
Earlier patternsChart patterns that were detected for this asset earlier, each with its outcome: target 1 reached, stop reached (invalid), time limit over or still open. A list of the past, not a forecast.Example: Example: “Flag, detected on 3 Sep, target 1 reached on 22 Sep” – describes that one case, not the next pattern.More in the Academy: Glossary
Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure
1Wweekly candles↔ mixed
Close below the SMA 200
EMA 20 above the EMA 50
higher highs and higher lows
Price below the EMA 20 · above the EMA 50
Week to Nov 20, 2026
1Ddaily candles↔ mixed
Close above the SMA 200
EMA 20 above the EMA 50
Highs and lows mixed
Price below the EMA 20 · below the EMA 50
Daily candle of Nov 20, 2026
4H4-hour candles↔ mixed
Close below the SMA 200
EMA 20 below the EMA 50
Highs and lows mixed
Price below the EMA 20 · below the EMA 50
Candle from Nov 20, 2026, 19:30
Rule per timeframe: up = close above the SMA 200, EMA 20 above the EMA 50 and higher highs and lows; down = everything the other way round; otherwise mixed. Completed candles only, no overall score, no forecast. In the screener: all three up →
What does the daily chart show right now – line by line, without an overall verdict?
Technicals in plain words
Technicals in plain wordsFour lines on the daily chart – trend, momentum, volume, volatility –, each with its metric and threshold. We do not add the lines up or give a grade; they describe the price history so far.Example: RSI 64 → between 30 and 70, neither overbought nor oversold.More in the Academy: Lesson reading the RSI
Over the last 3 months it ran stronger than the S&P 500 and weaker than the median of the sector “Health Care”.
vs. S&P 500 · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. S&P 500 · 6 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. sector · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
weaker
Trendabove SMA 200Price above the 200-day line – above it the long-term trend counts as up; ADX below 20 – hardly any trend.
MomentumneutralRSI between 30 and 70 – neither overbought nor oversold; MACD line fell below its signal line in the last 5 trading days.
Volumenot elevatedVolume on the last trading day below 1.5 times the average of up to 50 trading days before – not elevated.
VolatilitynormalTypical daily range (ATR 14) between 2 and 4% of the price – normal.
The figures behind it – distance to the line, RSI, volume, volatility and relative strength in percentage points – are visible with a free account.Sign up free
More depth
How we read the lines
Each line stands on its own – we do not add them up and give no grade.
Trend: the 200-day line is the average of the last 200 closing prices. The ADX (14) measures how pronounced a trend is, not its direction: below 20 hardly any trend, above 25 pronounced.
Momentum: the RSI (14) lies between 0 and 100; below 30 it counts as oversold, above 70 as overbought. The MACD (12/26) compares two averages, the signal line (9) smooths it.
Volume: shares traded on the last trading day divided by the average of up to 50 trading days before; from 1.5x elevated, from 2x unusually high, from 3x very high.
Volatility: typical daily range (ATR 14) as a percentage of the price; below 2% calm, 2 to 4% normal, above 4% high. Squeeze = Bollinger Bands as narrow as on at most a fifth of the last 120 trading days.
Relative strength: the stock’s price change minus that of the benchmark over the same period (3 months = 91 days, 6 months = 182 days), in percentage points, from completed daily candles. Benchmark: the S&P 500 (ETF SPY) or the median of the stocks of the same sector in our selection (at least 5 others with a candle on the same day). Dividends are not included.
Against the sector median over 6 months: ran weaker.
All figures describe the price history so far – they do not say what happens next.
As of: daily candle of Nov 20, 2026 · from our daily candles
How did this asset do in each calendar month over the last 10 years?
Seasonality
SeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
In November, the stock closed higher in 8 of 10 years – the S&P 500 in 9 of 10.
Years higher in NovemberSeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
8 of 10
2016 to 2025
S&P 500 in November
9 of 10
years higher, same years as above (ETF SPY)
Months mostly higher
5 of 12
Calendar months that closed higher in more than half of the years
You can see the median and range per month in percent with a free account.Sign up free
5/10Jan
5/10Feb
5/10Mar
8/10Apr
7/10May
5/10Jun
5/10Jul
7/10Aug
2/10Sep
8/10Oct
8/10Nov
5/10Dec
January: higher in 5 of 10 years
February: higher in 5 of 10 years
March: higher in 5 of 10 years
April: higher in 8 of 10 years
May: higher in 7 of 10 years
June: higher in 5 of 10 years
July: higher in 5 of 10 years
August: higher in 7 of 10 years
September: higher in 2 of 10 years
October: higher in 8 of 10 years
November (current month): higher in 8 of 10 years
December: higher in 5 of 10 years
Past performance, not a forecast · Bar = share of years higher, line = half · Price return without dividendsMore depth
How we calculate
Monthly return = closing price on the last trading day of the month ÷ closing price on the last trading day of the previous month − 1. Price return without dividends.
Only completed months count, never the current one. If the candle of the last trading day is missing, the month does not count.
For each calendar month the last 10 years in which it has ended; from 8 years with a value we show the median, years higher and the range. “Higher” means: return above 0.0%.
Past performance, not a forecast: the figures describe earlier years and do not tell how the next month will go.
By calendar month (● = current month)
Month
Years higher
January
5 of 10
February
5 of 10
March
5 of 10
April
8 of 10
May
7 of 10
June
5 of 10
July
5 of 10
August
7 of 10
September
2 of 10
October
8 of 10
November ●
8 of 10
December
5 of 10
Through October 2026 (last completed month) · from our daily candles
Opportunity at a glance Elevance Health
There is no opportunity card on 1-hour candles: we calculate patterns, targets and supports on the 4H, daily and weekly charts.
What does this mean? The card sums up chart patterns, potential to target, risk to stop and supports of Elevance Health on the 4H, daily and weekly charts – every figure with its timeframe.
Potential to target 1●● %hidden4-hour or daily chart
Risk to stop
●● %hidden
Reward/risk
● : 1hidden
Remaining potential: moved since detection and still open to target 1 – each in % with timeframe.
Potential to target on the weekly chart●● %hiddenWeekly chart
Invalid below (weekly close)
●● %hidden
Supports below
3
Supports below with distance in %, timeframe and number of tests (possible levels to add).
Trend Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure4H↔ mixed1D↔ mixed1W↔ mixed
In favour2 · Against0Points without chart-pattern detail – you see every point with figure and date with a free account
You see all figures, supports, for and against, and similar stocks with a free account.Create a free account
Calculated automatically by fixed rules – not investment advice. How we analyze
Potential
This shows the distance from the last close to the pattern’s target mark – a distance, not a return. Next to it the risk to the stop, each with the timeframe the figure comes from.
Supports below
Under “Long term” you find price areas below the price where it has already turned several times – with distance in percent, timeframe and number of tests. They describe where the price found support before.
For · Against
Fixed rules collect facts that speak for or against the picture, each with its date. There is deliberately no total and no grade – you do the weighing yourself.
My plan
“My plan” remembers your holding period and a target level of your own and lets you know when the price reaches the entry area. That and all figures of the card are available with a free account.
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Elevance Health · Sector Health Care · amounts in USD
Source: SEC filings, As of Feb 6, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.1x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
–no data: Gross margin above 40%reported cost of revenue covers only part of the costs (margin more than 60 percentage points above the operating margin)
✗not met: Operating margin above 15%3.6%
✗not met: Net margin above 10%2.8%
✗not met: Return on equity above 15%12.9%
✗not met: Free cash flow margin above 10%1.6%
✓met: Profit in each of the last 5 fiscal years5 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✓met: Equity ratio above 30%36.1%
Operating margin
3.6%Fiscal year 2025
All21weak
Rank 21 of 100: higher than 21% of 470 peers (All). weak.
Sector25weak
Rank 25 of 100: higher than 25% of 54 peers (Sector). weak.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
2.8%Fiscal year 2025
All20weak
Rank 20 of 100: higher than 20% of 584 peers (All). weak.
Sector23weak
Rank 23 of 100: higher than 23% of 63 peers (Sector). weak.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on equity
12.9%Fiscal year 2025
All49medium
Rank 49 of 100: higher than 49% of 544 peers (All). medium.
Sector51medium
Rank 51 of 100: higher than 51% of 54 peers (Sector). medium.
Median Health Care: 12.8%
Net income divided by equity at fiscal year end.
Return on assets
4.7%Fiscal year 2025 (total assets at year end)
All47medium
Rank 47 of 100: higher than 47% of 594 peers (All). medium.
Sector39medium
Rank 39 of 100: higher than 39% of 63 peers (Sector). medium.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
36.1%Fiscal year 2025
All49medium
Rank 49 of 100: higher than 49% of 595 peers (All). medium.
Sector37medium
Rank 37 of 100: higher than 37% of 63 peers (Sector). medium.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
1.6%Fiscal year 2025
All19weak
Rank 19 of 100: higher than 19% of 465 peers (All). weak.
Sector14weak
Rank 14 of 100: higher than 14% of 61 peers (Sector). weak.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
3.2B USDFiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
Growth 6 of 7 met
✓met: Over 3 years, revenue grew by more than 5% per year+8.3%
✓met: Over 5 years, revenue grew by more than 5% per year+10.3%
✓met: Over 10 years, revenue grew by more than 5% per year+9.7%
✗not met: Over 3 years, EPS grew by more than 5% per year+0.5%
✓met: Over 5 years, EPS grew by more than 5% per year+7.0%
✓met: Revenue rose in at least 4 of the last 5 fiscal years5 of 5
✓met: Revenue rose in the last fiscal year+12.5%
Revenue growth 3 years
+8.3%per year
All61medium
Rank 61 of 100: higher than 61% of 578 peers (All). medium.
Sector67strong
Rank 67 of 100: higher than 67% of 62 peers (Sector). strong.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+10.3%per year
All59medium
Rank 59 of 100: higher than 59% of 549 peers (All). medium.
Sector63medium
Rank 63 of 100: higher than 63% of 60 peers (Sector). medium.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+9.7%per year
All69strong
Rank 69 of 100: higher than 69% of 412 peers (All). strong.
Sector55medium
Rank 55 of 100: higher than 55% of 50 peers (Sector). medium.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
+0.5%per year
All33medium
Rank 33 of 100: higher than 33% of 437 peers (All). medium.
Sector36medium
Rank 36 of 100: higher than 36% of 54 peers (Sector). medium.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
+7.0%per year
All33medium
Rank 33 of 100: higher than 33% of 399 peers (All). medium.
Sector41medium
Rank 41 of 100: higher than 41% of 47 peers (Sector). medium.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
+10.4%per year
All54medium
Rank 54 of 100: higher than 54% of 375 peers (All). medium.
Sector55medium
Rank 55 of 100: higher than 55% of 46 peers (Sector). medium.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 7 of 7 met
✓met: Pays a dividend6.84 USD
✓met: Payout ratio at most 60% of earnings27%
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✓met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.never
✓met: Dividend per share higher than 5 years ago+12.5%
✓met: Free cash flow per share covers the dividend2.1x
✓met: Dividends paid over the last 5 years covered by free cash flow23% of free cash flow
Payout ratio
27%Fiscal year 2025
Dividend per share divided by earnings per share.
Dividend growth 5 years
+12.5%per year
All75strong
Rank 75 of 100: higher than 75% of 321 peers (All). strong.
Sector76strong
Rank 76 of 100: higher than 76% of 31 peers (Sector). strong.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
2.1xFiscal year 2025
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 6 of 6 met
✓met: Piotroski F-Score at least 7 of 97 of 9
✓met: Long-term debt no higher than equity0.73
✓met: Current assets cover current liabilities1.54
✓met: Positive equity43.9B USD
✓met: In 5 years, share count up by at most 5%−11.7%
✓met: Free cash flow positive in the last fiscal year3.2B USD
Piotroski F-Score
7 of 9Fiscal year 2025
All69strong
Rank 69 of 100: higher than 69% of 310 peers (All). strong.
Sector65medium
Rank 65 of 100: higher than 65% of 47 peers (Sector). medium.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
0.73at fiscal year end
All43medium
Rank 43 of 100: lower than 43% of 486 peers (All). medium.
Sector33medium
Rank 33 of 100: lower than 33% of 50 peers (Sector). medium.
Median Health Care: 0.66
Long-term financial debt divided by equity.
Liquidity (current ratio)
1.54at fiscal year end
All58medium
Rank 58 of 100: higher than 58% of 513 peers (All). medium.
Sector44medium
Rank 44 of 100: higher than 44% of 63 peers (Sector). medium.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−11.7%in 5 years
All79strong
Rank 79 of 100: lower than 79% of 507 peers (All). strong.
Sector81strong
Rank 81 of 100: lower than 81% of 59 peers (Sector). strong.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✗not met: Return on assets higher than the prior year
✗not met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✓met: Liquidity (current assets / current liabilities) rose
✓met: No additional shares (diluted share count did not rise)
✓met: Gross margin higher than the prior year
✓met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light green: Revenue grew over 5 years (+10.3% per year), at least as fast as the sector median.
Light yellow: Net income (total) grew over 5 years (+4.4% per year), more slowly than the sector median; per share +7.0% per year.
Light yellow: Net margin 2.8%, below the sector median (13.9%).
Light yellow: Debt higher than usual in the sector.
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
050B100B150B200B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 84.9B USD · Net income 2.5B USD · Net margin 2.9%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 90.0B USD · Net income 3.8B USD · Net margin 4.3%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 92.1B USD · Net income 3.8B USD · Net margin 4.1%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 104.2B USD · Net income 4.8B USD · Net margin 4.6%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 121.9B USD · Net income 4.6B USD · Net margin 3.8%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 138.6B USD · Net income 6.1B USD · Net margin 4.4%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 156.6B USD · Net income 6.0B USD · Net margin 3.8%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 171.3B USD · Net income 6.0B USD · Net margin 3.5%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 177.0B USD · Net income 6.0B USD · Net margin 3.4%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 199.1B USD · Net income 5.7B USD · Net margin 2.8%
Margin
2.9%4.3%4.1%4.6%3.8%4.4%3.8%3.5%3.4%2.8%
RevenueNet incomeNet margin (below)in USD
020B40B60B
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 42.6B USD · Net income 856.0M USD · Net margin 2.0% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 42.6B USD · Net income 2.2B USD · Net margin 5.3%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 43.9B USD · Net income 2.3B USD · Net margin 5.2%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 45.1B USD · Net income 1.0B USD · Net margin 2.3%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 45.4B USD · Net income 418.0M USD · Net margin 0.9% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 48.9B USD · Net income 2.2B USD · Net margin 4.5%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 49.8B USD · Net income 1.7B USD · Net margin 3.5%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 50.7B USD · Net income 1.2B USD · Net margin 2.3%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 49.7B USD · Net income 547.0M USD · Net margin 1.1% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 50.2B USD · Net income 1.8B USD · Net margin 3.5%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 50.5B USD · Net income 1.5B USD · Net margin 2.9%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 51.4B USD · Net income 1.4B USD · Net margin 2.7%
Margin
2.0%5.3%5.2%2.3%0.9%4.5%3.5%2.3%1.1%3.5%2.9%2.7%
Earnings per shareUSD per share
0102030
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 9.21 USD
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 14.35 USD
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share 14.19 USD
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 18.47 USD
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 17.98 USD
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 24.73 USD
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 24.81 USD
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 25.22 USD
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 25.68 USD
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 25.21 USD
Earnings per shareUSD per share
02.505.007.5010
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share not reported separately for Q4
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 9.59 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share 9.85 USD
Dividend per sharePayout ratio (below)USD per share
02.004.006.00
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Dividend per share 2.60 USD · Payout ratio 28.2%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Dividend per share 2.70 USD · Payout ratio 18.8%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Dividend per share 3.00 USD · Payout ratio 21.1%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Dividend per share 3.20 USD · Payout ratio 17.3%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Dividend per share 3.80 USD · Payout ratio 21.1%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Dividend per share 4.52 USD · Payout ratio 18.3%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Dividend per share 5.12 USD · Payout ratio 20.6%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Dividend per share 5.92 USD · Payout ratio 23.5%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Dividend per share not available · Payout ratio not available
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Dividend per share not available · Payout ratio not available
Ratio
28%19%21%17%21%18%21%23%
Dividend per sharePayout ratio (below)USD per share
00.501.001.502.00
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 1.48 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 1.63 USD · Payout ratio 17.0%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 1.63 USD · Payout ratio 16.5%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 1.63 USD · Payout ratio 37.4%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 1.63 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 1.71 USD · Payout ratio 17.8%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 1.71 USD · Payout ratio 22.2%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 1.71 USD · Payout ratio 32.1%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 1.71 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 1.72 USD · Payout ratio 21.5%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 1.72 USD · Payout ratio 25.6%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 1.72 USD · Payout ratio 27.4%
Ratio
17%17%37%18%22%32%22%26%27%
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 199.1B USD · Net income 5.7B USD · Net margin 2.8%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +1.4% vs. the same quarter a year earlier; grown for at least 16 quarters in a row.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
3.2%
Fiscal year 2025: 1.6%
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Dec 31, 2025 199.1B USD + year to date to Sep 30, 2026 152.1B USD − same period a year earlier to Sep 30, 2025 149.4B USD = 201.8B USD
Net income: fiscal year to Dec 31, 2025 5.7B USD + year to date to Sep 30, 2026 4.6B USD − same period a year earlier to Sep 30, 2025 5.1B USD = 5.1B USD
Operating cash flow: fiscal year to Dec 31, 2025 4.3B USD + year to date to Sep 30, 2026 7.5B USD − same period a year earlier to Sep 30, 2025 4.2B USD = 7.6B USD
Capital expenditure: fiscal year to Dec 31, 2025 1.1B USD + year to date to Sep 30, 2026 789.0M USD − same period a year earlier to Sep 30, 2025 823.0M USD = 1.1B USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
51.4B
+1.4%
1.4B
2.7%
Apr–Jun 26
50.5B
+1.4%
1.5B
2.9%
Jan–Mar 26
50.2B
+2.6%
1.8B
3.5%
Oct–Dec 25*
49.7B
+9.5%
547.0M
1.1%
Jul–Sep 25
50.7B
+12.4%
1.2B
2.3%
Apr–Jun 25
49.8B
+13.4%
1.7B
3.5%
Jan–Mar 25
48.9B
+14.8%
2.2B
4.5%
Oct–Dec 24*
45.4B
+6.6%
418.0M
0.9%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
As of: 12 months to Sep 30, 2026, filed on Oct 21, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is well above the cash coming in from the business; interest is well covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
0.76x
0.81.0
backed from 1.0 · 3 years: 1.03x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
5.1x
25
well covered from 5 · 3 years: 6.5x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2025 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years no loss year and no year with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
0 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
0 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
1.8 percentage points
from 2.8% to 4.6%
20162025Net margin by fiscal yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2025
+12.5%
2.8%
2024
+3.3%
3.4%
2023
+9.4%
3.5%
2022
+13.0%
3.8%
2021
+13.8%
4.4%
2020
+16.9%
3.8%
2019
+13.1%
4.6%
2018
+2.3%
4.1%
2017
+6.1%
4.3%
2016
+7.2%
2.9%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2016–2025 · Source: SEC filings
Since when has today’s status held?
Check status by fiscal year
Check status by fiscal yearPoints of the four quality checks without price data by fiscal year: earlier years recalculated as of the filing date of their annual report with the figures known then, the latest year with today’s status. This shows since when today’s status has held.Example: Quality 7 of 8 in the annual reports 2022 to 2025, still 6 of 8 in 2021 → since fiscal year 2022.More in the Academy: Guide fundamental analysis
Quality: 3 of 7 criteria in every annual report since 2024; Financial strength in fiscal year 2025: 6 of 6 (prior year 5 of 6).
Quality3 of 7since FY 2024 · before that 4 of 7
Growth6 of 7since FY 2024 · before that 7 of 7
Dividend7 of 7in every annual report since 2021
Financial strength6 of 6since FY 2025 · before that 5 of 6
More depth
Criteria met by fiscal year (met/with data)
Check
2021
2022
2023
2024
2025
Quality
4/7
4/7
4/7
3/7
3/7
Growth
7/7
7/7
7/7
6/7
6/7
Dividend
7/7
7/7
7/7
7/7
7/7
Financial strength
5/6
5/6
6/6
5/6
6/6
Fiscal year 2025 with today’s status of the checks without price data (for accounts, the badges above also count P/E/PEG and dividend yield).
Earlier years as of the filing date of their annual report: FY 2024 on Feb 20, 2025, FY 2023 on Feb 21, 2024, FY 2022 on Feb 15, 2023, FY 2021 on Feb 16, 2022.
Recalculated only with SEC filings up to the respective filing date – later corrections are left out. Without price-based criteria (P/E, dividend yield); criteria without data do not count.
As of annual reports 2021–2025 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2025
Of 100 USD of revenue, 3.6 USD operating income and 2.8 USD net income remained.
Revenue199.1B USD · 100%Operating income7.2B USD · 4%Cost of revenue and operating expenses191.9B USD · 96%Net income5.7B USD · 3%Interest expense1.4B USD · 1%Taxes & other (net)135.0M USD · 0%
Money flow as a table
Fiscal year 2025, amounts in USD, share of revenue
Item
Amount
of revenue
Revenue
199.1B USD
100.0%
Operating income
7.2B USD
3.6%
Cost of revenue and operating expenses
191.9B USD
96.4%
Net income
5.7B USD
2.8%
Interest expense
1.4B USD
0.7%
Taxes & other (net)
135.0M USD
0.1%
Taxes, interest and other items are not available separately in the SEC data; they are combined as the difference.
Margins
The operating margin fell in 5 years from 5.2% to 3.6%.
Operating marginNet margin
0%2%4%6%
2016Fiscal year 2016: Operating margin 5.7% · Net margin 2.9%
2017Fiscal year 2017: Operating margin 4.6% · Net margin 4.3%
2018Fiscal year 2018: Operating margin 5.9% · Net margin 4.1%
2019Fiscal year 2019: Operating margin 5.8% · Net margin 4.6%
2020Fiscal year 2020: Operating margin 5.2% · Net margin 3.8%
2021Fiscal year 2021: Operating margin 5.4% · Net margin 4.4%
2022Fiscal year 2022: Operating margin 5.4% · Net margin 3.8%
2023Fiscal year 2023: Operating margin 5.0% · Net margin 3.5%
2024Fiscal year 2024: Operating margin 4.4% · Net margin 3.4%
2025Fiscal year 2025: Operating margin 3.6% · Net margin 2.8%
Returns
Return on equity stayed roughly the same in 5 years (12.9%).
Return on equityReturn on assets
0%5%10%15%20%
2016Fiscal year 2016: Return on equity 9.8% · Return on assets 3.8%
2017Fiscal year 2017: Return on equity 14.5% · Return on assets 5.4%
2018Fiscal year 2018: Return on equity 13.1% · Return on assets 5.2%
2019Fiscal year 2019: Return on equity 15.2% · Return on assets 6.2%
2020Fiscal year 2020: Return on equity 13.8% · Return on assets 5.3%
2021Fiscal year 2021: Return on equity 16.9% · Return on assets 6.3%
2022Fiscal year 2022: Return on equity 16.6% · Return on assets 5.9%
2023Fiscal year 2023: Return on equity 15.2% · Return on assets 5.5%
2024Fiscal year 2024: Return on equity 14.5% · Return on assets 5.1%
2025Fiscal year 2025: Return on equity 12.9% · Return on assets 4.7%
Equity and long-term debt
The equity ratio fell in 5 years from 38.3% to 36.1%.
EquityLong-term debtin USDLong-term debt, depending on the filing, includes the current portion or leases.
2016Fiscal year 2016: Operating cash flow 3.2B USD · Capital expenditure 583.6M USD · Free cash flow 2.6B USD
2017Fiscal year 2017: Operating cash flow 4.2B USD · Capital expenditure 799.5M USD · Free cash flow 3.4B USD
2018Fiscal year 2018: Operating cash flow 3.8B USD · Capital expenditure 1.2B USD · Free cash flow 2.6B USD
2019Fiscal year 2019: Operating cash flow 6.1B USD · Capital expenditure 1.1B USD · Free cash flow 5.0B USD
2020Fiscal year 2020: Operating cash flow 10.7B USD · Capital expenditure 1.0B USD · Free cash flow 9.7B USD
2021Fiscal year 2021: Operating cash flow 8.4B USD · Capital expenditure 1.1B USD · Free cash flow 7.3B USD
2022Fiscal year 2022: Operating cash flow 8.4B USD · Capital expenditure 1.2B USD · Free cash flow 7.2B USD
2023Fiscal year 2023: Operating cash flow 8.1B USD · Capital expenditure 1.3B USD · Free cash flow 6.8B USD
2024Fiscal year 2024: Operating cash flow 5.8B USD · Capital expenditure 1.3B USD · Free cash flow 4.6B USD
2025Fiscal year 2025: Operating cash flow 4.3B USD · Capital expenditure 1.1B USD · Free cash flow 3.2B USD
Share count
The share count fell in 5 years by 11.7% (mostly through share repurchases).
Diluted share count
0100M200M300M
2016Fiscal year 2016: Diluted share count 268.1M
2017Fiscal year 2017: Diluted share count 267.8M
2018Fiscal year 2018: Diluted share count 264.2M
2019Fiscal year 2019: Diluted share count 260.3M
2020Fiscal year 2020: Diluted share count 254.3M
2021Fiscal year 2021: Diluted share count 246.8M
2022Fiscal year 2022: Diluted share count 242.8M
2023Fiscal year 2023: Diluted share count 237.4M
2024Fiscal year 2024: Diluted share count 232.9M
2025Fiscal year 2025: Diluted share count 224.6M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Net margin
The net margin stayed roughly the same in 5 years (2.8%).
ELVSector today 13.9%Mark in the latest year: today’s median of the Health Care sector as in the sector comparison (each latest fiscal year). We do not have earlier medians.
0%5%10%15%
2016Fiscal year 2016: ELV 2.9%
2017Fiscal year 2017: ELV 4.3%
2018Fiscal year 2018: ELV 4.1%
2019Fiscal year 2019: ELV 4.6%
2020Fiscal year 2020: ELV 3.8%
2021Fiscal year 2021: ELV 4.4%
2022Fiscal year 2022: ELV 3.8%
2023Fiscal year 2023: ELV 3.5%
2024Fiscal year 2024: ELV 3.4%
2025Fiscal year 2025: ELV 2.8% · Sector today 13.9%
Return on equity
Return on equity stayed roughly the same in 5 years (12.9%).
ELVSector today 14.3%
0%5%10%15%20%
2016Fiscal year 2016: ELV 9.8%
2017Fiscal year 2017: ELV 14.5%
2018Fiscal year 2018: ELV 13.1%
2019Fiscal year 2019: ELV 15.2%
2020Fiscal year 2020: ELV 13.8%
2021Fiscal year 2021: ELV 16.9%
2022Fiscal year 2022: ELV 16.6%
2023Fiscal year 2023: ELV 15.2%
2024Fiscal year 2024: ELV 14.5%
2025Fiscal year 2025: ELV 12.9% · Sector today 14.3%
Free cash flow margin
The free cash flow margin fell in 5 years from 7.9% to 1.6%.
ELVSector today 14.9%
0%5%10%15%
2016Fiscal year 2016: ELV 3.1%
2017Fiscal year 2017: ELV 3.8%
2018Fiscal year 2018: ELV 2.8%
2019Fiscal year 2019: ELV 4.8%
2020Fiscal year 2020: ELV 7.9%
2021Fiscal year 2021: ELV 5.2%
2022Fiscal year 2022: ELV 4.6%
2023Fiscal year 2023: ELV 3.9%
2024Fiscal year 2024: ELV 2.6%
2025Fiscal year 2025: ELV 1.6% · Sector today 14.9%
Source: SEC filings, fiscal years up to Dec 31, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.1x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
at least 10
as far as the data goes
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
+12.5%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
2.1x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2020 3.80 USD → fiscal year 2025 6.84 USD = +12.5% per year
Free cash flow per share 14.13 USD ÷ dividend per share 6.84 USD = 2.1x
Years without a cut: in a row up to fiscal year 2025, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is below its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
6.84USD · Fiscal year 2025
Dividend growth per year
3 y+10.1%5 y+12.5%10 y+10.6%
Payout ratio
of earnings27%of free cash flow48%
To shareholders (5 years)
19.2B USD65% through repurchases
Share count over 5 years
−11.7%fewer shares – each share is a larger stake
Dividend per share
The dividend per share rose in 5 years from 3.80 USD to 6.84 USD.
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
02.004.006.008.00
2016Fiscal year 2016: Dividend per share 2.60 USD
2017Fiscal year 2017: Dividend per share 2.70 USD
2018Fiscal year 2018: Dividend per share 3.00 USD
2019Fiscal year 2019: Dividend per share 3.20 USD
2020Fiscal year 2020: Dividend per share 3.80 USD
2021Fiscal year 2021: Dividend per share 4.52 USD
2022Fiscal year 2022: Dividend per share 5.12 USD
2023Fiscal year 2023: Dividend per share 5.92 USD
2024Fiscal year 2024: Dividend per share 6.52 USD
2025Fiscal year 2025: Dividend per share 6.84 USD
Payout ratios
The payout ratio rose in 5 years from 21.1% to 27.1%.
Payout ratio (earnings)Payout ratio (free cash flow)
0%20%40%60%
2016Fiscal year 2016: Payout ratio (earnings) 28.2% · Payout ratio (free cash flow) 26.1%
2017Fiscal year 2017: Payout ratio (earnings) 18.8% · Payout ratio (free cash flow) 20.8%
2018Fiscal year 2018: Payout ratio (earnings) 21.1% · Payout ratio (free cash flow) 29.6%
2019Fiscal year 2019: Payout ratio (earnings) 17.3% · Payout ratio (free cash flow) 16.4%
2020Fiscal year 2020: Payout ratio (earnings) 21.1% · Payout ratio (free cash flow) 9.9%
2021Fiscal year 2021: Payout ratio (earnings) 18.3% · Payout ratio (free cash flow) 15.2%
2022Fiscal year 2022: Payout ratio (earnings) 20.6% · Payout ratio (free cash flow) 17.0%
2023Fiscal year 2023: Payout ratio (earnings) 23.5% · Payout ratio (free cash flow) 20.6%
2024Fiscal year 2024: Payout ratio (earnings) 25.4% · Payout ratio (free cash flow) 33.1%
2025Fiscal year 2025: Payout ratio (earnings) 27.1% · Payout ratio (free cash flow) 48.2%
What goes back to shareholders
Over 5 years, 19.2B USD went back to shareholders, 65% of it through share repurchases. That is 66% of the free cash flow of those years.
2021Fiscal year 2021: Dividends paid 1.1B USD · Share repurchases 1.9B USD · New shares issued (including employee plans) not available · Free cash flow 7.3B USD
2022Fiscal year 2022: Dividends paid 1.2B USD · Share repurchases 2.3B USD · New shares issued (including employee plans) not available · Free cash flow 7.2B USD
2023Fiscal year 2023: Dividends paid 1.4B USD · Share repurchases 2.7B USD · New shares issued (including employee plans) not available · Free cash flow 6.8B USD
2024Fiscal year 2024: Dividends paid 1.5B USD · Share repurchases 2.9B USD · New shares issued (including employee plans) not available · Free cash flow 4.6B USD
2025Fiscal year 2025: Dividends paid 1.5B USD · Share repurchases 2.6B USD · New shares issued (including employee plans) not available · Free cash flow 3.2B USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Elevance Health next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison ELV, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+10.3%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 10.3% per year on average – at least as fast as the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+4.4%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: +7.0% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 4.4% per year on average, but more slowly than the median company in the sector (+5.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 2.84 USD remained as profit – less than the median company in the sector (13.9%). Five years ago the margin was 3.8%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light yellow: higher than sector
0.69latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 0.69 USD of financial debt – more than the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light gray: none found
–Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
199.1B USD
Revenue vs. prior year
+12.5%
Net income (FY)
5.7B USD
Net income vs. prior year
−5.3%
EPS (FY)
25.21 USD
Superinvestors holding
2 of 26
Fiscal year to Dec 31, 2025 · 10-K filed Feb 6, 2026 · Balance sheet Sep 30, 2026 (filed Oct 21, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
199.1B
5.7B
2.8%
25.21
–
–
2024
Dec 31, 2024
177.0B
6.0B
3.4%
25.68
–
–
2023
Dec 31, 2023
171.3B
6.0B
3.5%
25.22
5.92
23%
2022
Dec 31, 2022
156.6B
6.0B
3.8%
24.81
5.12
21%
2021
Dec 31, 2021
138.6B
6.1B
4.4%
24.73
4.52
18%
2020
Dec 31, 2020
121.9B
4.6B
3.8%
17.98
3.80
21%
2019
Dec 31, 2019
104.2B
4.8B
4.6%
18.47
3.20
17%
2018
Dec 31, 2018
92.1B
3.8B
4.1%
14.19
3.00
21%
2017
Dec 31, 2017
90.0B
3.8B
4.3%
14.35
2.70
19%
2016
Dec 31, 2016
84.9B
2.5B
2.9%
9.21
2.60
28%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
51.4B
1.4B
2.7%
6.27
1.72
27%
Q2/26
Jun 30, 2026
50.5B
1.5B
2.9%
6.71
1.72
26%
Q1/26
Mar 31, 2026
50.2B
1.8B
3.5%
8.00
1.72
22%
Q4/25*
Dec 31, 2025
49.7B
547.0M
1.1%
–
1.71
–
Q3/25
Sep 30, 2025
50.7B
1.2B
2.3%
5.32
1.71
32%
Q2/25
Jun 30, 2025
49.8B
1.7B
3.5%
7.72
1.71
22%
Q1/25
Mar 31, 2025
48.9B
2.2B
4.5%
9.61
1.71
18%
Q4/24*
Dec 31, 2024
45.4B
418.0M
0.9%
–
1.63
–
Q3/24
Sep 30, 2024
45.1B
1.0B
2.3%
4.36
1.63
37%
Q2/24
Jun 30, 2024
43.9B
2.3B
5.2%
9.85
1.63
17%
Q1/24
Mar 31, 2024
42.6B
2.2B
5.3%
9.59
1.63
17%
Q4/23*
Dec 31, 2023
42.6B
856.0M
2.0%
–
1.48
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Elevance Health?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 13, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score +25
Price vs. EMA 50-15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+0
Highs and lows-10
Price change 60 days+15
Volatility and trend strength
ADX 14 (trend strength)hardly any trend (below 20)
Price change 60 daysup
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.